Cardiogenesis Corporation to Present at the 5th Annual Stem Cell Summit

IRVINE, Calif., Feb. 9  /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP),announced today that Paul J. McCormick, Executive Chairman, is scheduled to present at the 5th Annual Stem Cell Summit in New York on Tuesday, February 16, 2010 at 3:21 pm Eastern time.

The annual Stem Cell Summits bring together for one day the leading industry, investment and research innovators within the rapidly expanding and highly competitive field of stem cells. The 2010 Summit will focus on the latest challenges in commercializing stem cell products and feature 35 corporate presenters, keynote speaker Dr. Arnold Caplan, a scientific panel discussion, and corporate exhibitors. More formation about the 5th Annual Stem Cell Summit may be accessed at http://www.stemcellsummit.com/.

About Cardiogenesis Corporation

Cardiogenesis is a medical device company specializing in the therapies for the treatment of chronic cardiac ischemia. The company's market leading Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina. Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease.  For more information on the company and its products, please visit the Cardiogenesis website at http://www.cardiogenesis.com/. 

DATASOURCE: Cardiogenesis Corporation



CONTACT:  Paul McCormick, Executive Chairman of Cardiogenesis

Corporation, [phone]



Web Site:  http://www.cardiogenesis.com/

http://www.stemcellsummit.com/ 

Copyright